Cas:68739-90-2 O-benzyl-L-methionine toluene-p-sulphonate manufacturer & supplier

Chemical Name:O-benzyl-L-methionine toluene-p-sulphonate

CAS.NO:68739-90-2

Synonyms:TosOH*Met-OBzl;methionine benzyl ester p-toluenesulfonate;EINECS 272-130-8;O-Benzyl-L-methionine toluene-p-sulphonate;L-methionine benzyl ester p-toluenesulfonate;H-Met-OBn*TsOH;H-Met-OBn*TosOH

Molecular Formula:C₁₉H₂₅NO₅S₂

Molecular Weight:411.53600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:598ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:140.37000

Exact Mass:411.11700

LogP:4.83300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like TosOH*Met-OBzl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-Met-OBn*TosOH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TosOH*Met-OBzl Use and application,EINECS 272-130-8 technical grade,usp/ep/jp grade.

Related News: Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said. O-benzyl-L-methionine toluene-p-sulphonate manufacturer The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. O-benzyl-L-methionine toluene-p-sulphonate supplier Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. O-benzyl-L-methionine toluene-p-sulphonate vendor The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. O-benzyl-L-methionine toluene-p-sulphonate factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.